Skip to main content

College of Pharmacy

Pharmacy Newsroom

February 18, 2026

Researcher Joins $3.2 Million Effort to Develop Promising New Breast Cancer Treatment

Wei Wang, Ph.D., research associate professor, has joined a $3.2 million effort to develop a promising new treatment for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease. The team is developing a new kind of drug designed to attack MDM2, a cancer-driving protein often found at high levels in TNBC and has been linked to faster tumor growth and worse outcomes for patients.

Top Stories

February 20, 2026

Postdoctoral Research Scientist Earns AHA Fellowship to Uncover New Mechanism in Rare Heart Disease

Luqi Zhao, M.D., University of Houston College of Pharmacy postdoctoral research scientist in the Department of Pharmacological & Pharmaceutical Sciences (PPS), is working to uncover a new mechanism in left ventricular non-compaction. She has received a two-year, $163,864 postdoctoral fellowship from the American Heart Association to investigate the “Pathogenesis of acquired left ventricular non-compaction,” a rare and severe cardiomyopathy.

February 13, 2026

SSHP’s Residency Bootcamp Earns National Recognition from ASHP

For the second consecutive year, the UHCOP Chapter of the Student Society of Health-System Pharmacists (SSHP) has been recognized as a 2025-26 American Society of Health-System Pharmacy (ASHP) Outstanding Professional Development Award recipient for its Residency Bootcamp. The chapter was one of 17 nationwide to receive the honor from the ASHP Pharmacy Student Forum.

January 13, 2026

Rethinking Muscle Protection in Duchenne Muscular Dystrophy

UHCOP faculty researcher Anirban Roy, Ph.D., has received a $300,000 grant from the Muscular Dystrophy Association to support his work focusing on Transforming Growth Factor-β–Activated Kinase 1 (TAK1), a signaling protein known to regulate inflammation, muscle growth and cell survival, in the development and progression of Duchenne muscular dystrophy (DMD).

Latest News

February 20, 2026

Postdoctoral Research Scientist Earns AHA Fellowship to Uncover New Mechanism in Rare Heart Disease

Luqi Zhao, M.D., University of Houston College of Pharmacy postdoctoral research scientist in the Department of Pharmacological & Pharmaceutical Sciences (PPS), is working to uncover a new mechanism in left ventricular non-compaction. She has received a two-year, $163,864 postdoctoral fellowship from the American Heart Association to investigate the “Pathogenesis of acquired left ventricular non-compaction,” a rare and severe cardiomyopathy.

February 18, 2026

Researcher Joins $3.2 Million Effort to Develop Promising New Breast Cancer Treatment

Wei Wang, Ph.D., research associate professor, has joined a $3.2 million effort to develop a promising new treatment for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease. The team is developing a new kind of drug designed to attack MDM2, a cancer-driving protein often found at high levels in TNBC and has been linked to faster tumor growth and worse outcomes for patients.

February 17, 2026

College Mourns Passing of Beloved Educator Frank Bove (1938-2026)

Former University of Houston College of Pharmacy Professor Frank C. Bove, a beloved and respected faculty member for 26 years until retiring in 2002, passed Jan. 24 at the age of 87.

February 13, 2026

SSHP’s Residency Bootcamp Earns National Recognition from ASHP

For the second consecutive year, the UHCOP Chapter of the Student Society of Health-System Pharmacists (SSHP) has been recognized as a 2025-26 American Society of Health-System Pharmacy (ASHP) Outstanding Professional Development Award recipient for its Residency Bootcamp. The chapter was one of 17 nationwide to receive the honor from the ASHP Pharmacy Student Forum.

February 13, 2026

Tam Elected Fellow of American Academy of Microbiology

The American Academy of Microbiology, a leadership group within the American Society for Microbiology (ASM), has elected UHCOP Professor Vincent H. Tam, Pharm.D., FIDSA, FIDP, BCIDP, to the Fellowship Class of 2026.

February 2, 2026

UHCOP Expands Degree Plans to Offer Doctorate, Master of Science in Population Health & Pharmacoepidemiology

Addressing a growing demand for graduate training in evaluating medication safety, effectiveness and outcomes in real-world clinical settings, UHCOP is expanding its offerings within the Pharmaceutical Sciences graduate program. The college will now offer a Master of Science and a doctoral degree in Population Health & Pharmacoepidemiology.